NON-FINANCIAL PERFORMANCE INDICATORS AND OTHER SUCCESS FACTORS
EMPLOYEES
The Fresenius Group had 122,217 employees worldwide at the end of 2008. The increase of 8,036 or 7% (December 31, 2007: 114,181) was mainly due to acquisitions.
Employee numbers in the business segments were as follows:
| Number of employees | Dec 31, 2008 | Dec 31, 2007 | Change |
| Fresenius Medical Care | 68,050 | 64,662 | 5% |
| Fresenius Kabi | 20,457 | 16,964 | 21% |
| Fresenius Helios | 30,088 | 30,043 | 0% |
| Fresenius Vamed | 2,802 | 1,767 | 59% |
| Corporate/Other | 820 | 745 | 10% |
| Total | 122,217 | 114,181 | 7% |
The chart shows the distribution of our employees by region. These percentages roughly correspond to the sales contributions of the respective continents. With an increase of 7%, the number of employees has grown significantly in North America. This is mainly due to the APP Pharmaceuticals acquisition. The number of employees also rose strongly in Asia-Pacific, with an increase of 32%. This reflects the acquisition of Dabur Pharma and our fast-growing business in this region, where currency-adjusted sales growth was 22%. In Germany, 37,078 people are employed, an increase of 4% (2007: 35,789).
